Evolent Health's GAAP loss for the six months of 2021 was $18.914 million, down 15 times from $282.273 million in the previous year. Revenue declined 0.3% to $437.128 million from $438.531 million a year earlier.
Evolent Health's GAAP loss for the six months of 2021 was $18.914 million, down 15 times from $282.273 million in the previous year. Revenue declined 0.3% to $437.128 million from $438.531 million a year earlier. 
ir.evolenthealth.com
English (US) 